Novo Nordisk

weight loss scale weigh measure tape obesity overweight
Biotech

Lilly rounds out orforglipron data ahead of obesity filings

With a complete weight loss data set in hand, Lilly is eyeing regulatory filings for orforglipron and thinks approvals could start arriving next year.
Fraiser Kansteiner Sep 17, 2025 9:00am
obesity overweight weight loss weigh

Novo pushes ahead with amylin after seeing ph. 3 tolerability

Sep 16, 2025 8:12am
Novo Nordisk
Favicon Fierce Pharma

Novo Nordisk tells employees they must return to office Jan. 1

Sep 11, 2025 2:13pm
Doustdar
Favicon Fierce Pharma

Novo charts major restructuring, layoffs under new CEO

Sep 10, 2025 8:41am
liver

FDA considers new liver trial endpoint, sending MASH shares up

Aug 28, 2025 11:25am
Measuring tape on top of cash

Novo seeks obesity refresh with $550M Replicate deal

Aug 28, 2025 7:00am